UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, including zip code)
Registrant’s
telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
On October 22, 2021, in connection with and following its annual meeting of stockholders (“Annual Meeting”), Guardion Health Sciences, Inc. (the “Company”) delivered a presentation concerning the Company. The presentation will be posted on the “Investors” page of the Company’s website, www.guardionhealth.com, following the Annual Meeting. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 | Presentation dated October 2021 |
104 | Inline XBRL for the cover page of this Current Report on Form 8-K |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GUARDION HEALTH SCIENCES, INC. | ||
Date: October 22, 2021 | ||
By: | /s/ Bret Scholtes | |
Name: | Bret Scholtes | |
Title: | Chief Executive Officer |
Exhibit 99.1
E8EJ?WU;@/2NFCL<]7<-O-/=?EI.]/?[M;(Q97*TPK4II
MIJ6BDR)EXI@49J5LXJ, YJ2QVSBC%+S2XIB&XHVYIV*.:+!<;L%(4IW-'-*P
M7&[#2Q B9/\ >%&XBEBR9D_WA0D#>AIT445N8!1110 4444 %+24M !1110
M4444T 4"B@4P%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ I,9I:3KQ0(.#0!F@@)R:JSW:H/E/-2Y);E*+>Q8:15X
M)&*:)HLX##\ZR)+MI.YJ+S77D,?SK)U>B-%2ZLZ'.1\IH^M8-KJ;K,%8]QW-
M;B2B501W%:0J*1$H.(ZBBBK)"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ _'%4+M,R#YA5_K5"Z"^8/F-1/8J.Y#L (^
M=:7">OZTAC4D?,:<(QZUB:L $_R:7:GK^M C'K2^6/6F(3:GJ/SH"J#Q2^6/
M6@* >M,!X^]5>7_6BK(^_5>;_6BB0HEV/_5"I#VJ./\ U0J0]JT6QF]Q'^[5
M%OOU>?[M46^_4S+@)WIZTSO3UJ442"I%J->HJ5:M$,=28IU&*HD;BE%+BB@
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M]:E Q:***H HHHH #24II* "J\G^LJQ4$G^LJ6-$J_=%/%-7[HIU-""BBBF
M4444 )1110 R3I4:U+(.*C6H&(>M,4?.*D-1JW[RD-$D_P#J3^%5*N3_ .H/
MX53I3W*CL%%%%048N@2;H1^/\ZV;H'[/Q[5B>'P/(!^O\ZVKR0+:Y^E9T?X:
M9I67[QV,$YQ[TG:H8Y_,%2YS7,G [+17LONN/]HU<7K5.SZ-]3
M5Q>M$=@EN2T445H0%%%% "8HQ2T4 )BBEHH @'^LJ>H!_K*F-) Q:***8!11
M10 4444 %5Y/]95BJ\G^LI,"9?NBG4U?NBG4( HHHI@%%%% "8HQ2T4 -?I3
M%I[]*8*D 8<5"G^L%22'! IB#YQ4O %C2D_>*-L"
M7Z5="_/BJEJP$@%:OE@G(K.FKQ-)LDC'R^OUJ7 P $0^N134&!1-*(HMW >:J[VI-Q]:'(.5%OSS2>=576C>WK2Y@Y2UYM)Y
ME5M[^M*)&HN'*6/,-)O-0>8U'F-3N%B??2[S5?S&I?,:BX[$WF'.*E16?O\
MK53>:!,Z]*.9"Y66Y895QM;]:I36%Q*X8..O]ZI/M$AH\^3UI/E>XUS+8KSZ
M5 TT6 S%U> [)6E>>7>Q_#-2QS.CX!*CV-0GMMHS(!
MD_RK&[-6D]#IM*UYH6$;L64]SD]ZZVVG2ZB#1')([\5YA&Y'/>MS1M3DCG6-
M0??@>AKOPV*LU&1Q8C#WU1V_S=,#-*>,>M,22-P.1N/O3\*.A^M>GLSSF)FC
M-+2'I0 9HS29%&12N(=FBF[E+#%([9(Q0,7DMC<0/:E*DMT!]Z:[X QUIAFV
MIR0*3:"S)",/DL<8QBE!7.,FJANE"Y!!/M3TO8W7G@_6A36Q7*]RP[<="*K2;TX/6J4KS9^4$_C6
M;J-;&L87W-5=8FB]#CVJO=ZE)>IR=N/PJA''
"15
M%W9GY-
:
G/TJX+C@GUJJ2&Z4PN
8U',PY2Z;B
MD^T53WM1YC4/X?^^J;LNC
M_&?^^JN9SWIHLDE('%"B+F&+@#=M49[ 4["'JJG\*4\C%*%%4*XSRT!X5?RI
MLGE\?*,_2IN!3&"GZT!=C"HP#T^E+YD:KEB>?:G]L8I=J8'%*P7(1,K'@D4U
MPY88=L?6K)7 X!H7<1STIV"Y&F0/7ZT_)IX H.*+ 1XR#@8SW%,^>->&)^IJ
M? Q1Q185RNLDI!Y(QZ&HB;PME>G^]5S:G?K]:7/I1RCYB "X*_O ,?7-/VEA
MU(I_?K2Y--(3=R(JR\9)_&HR9 >%6K-!..]#07L18=EY;[225PWF.!Z!N
M*O8SSFF%P#S4\HU(B%NP4#>W'O2&-^A);ZFI?-7N*!*@_P#UT607(UA?_)IC
MVI.?6I_,0]_UH^3LPSVYHLAW90%D6<@NRY]#4Q@9 %$LA^IJ;)#Y+BG[SGY3
MFIY4/F9$L1 YE<^V:<(1_>-/SDY/6C&:JR)NQ@B4=?F^M*8T_N+^5.P1UHQ1
M9!=C?+'0<5D:V\C1^5&HRW!/3L:V@!GGI6?
FPK1L:D:84>)-!1I;FP::W7DSVQ\Q0/4XY ]R!5QK0ELR)49QW1S.>:?47 I